BEYOND è un nuovo programma post-dottorato Marie Skłodowska-Curie COFUND coordinato dalla Fondazione Telethon e da SR-Tiget e finanziato dalla Commissione Europea. Nei prossimi cinque anni, il programma recluterà 35 ricercatori post-dottorato di eccellenza presso istituzioni europee di primo piano in Italia, Svezia, Regno Unito e Slovenia. BEYOND offre un ambiente di formazione interdisciplinare che combina la ricerca all’avanguardia nelle terapie cellulari e geniche avanzate

Watch the first SITGEC Journal Club here.

Foundation For Rare Diseases (Fondation Maladies Rares, France) organises an online MOOC on gene and gene-based cell therapies for rare diseases . Foundation For Rare Diseases (Fondation Maladies Rares, France) organises an online MOOC on gene and gene-based cell therapies for rare diseases . The course features contributions from leading U.S. and European researchers — including Alain Fischer, Heather Gray Edwards, Alessio Cantore, Zoltan Ivics, Sylvie Odent, Salima Ha

SITGEC è profondamente addolorata per la scomparsa del Professor Claudio Bordignon.

SITGEC would like to congratulate Fondazione Telethon and HSR-TIGET on the milestone achievement of the FDA approval of WAS ex vivo gene therapy. Please see below their statement: We are honoured to share a moment of profound significance for us, for patients, families, and the scientific community. The U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Waskyra , the first gene therapy for the treatment of Wiskott-Aldrich syn

We would like to bring to your attention the upcoming EMBO Workshop titled “CRISPR-Cas: from biology to therapeutic applications”,...

Read the press release here for full details.

See a summary of SITGEC's headline numbers from 2024.

More than 1000 school students attended an event organised by Fondazione Telethon at the ESGCT/SITGEC Congress. Watch the event video here.